RTTNews | Sep 30, 2020 07:09AM EDT

07:09 Wednesday, September 30, 2020 (RTTNews) - Prelude Therapeutics Doses First Patient In Phase 1 Trial Of MCL1 Inhibitor PRT1419 For R/r Hematologic Malignancies

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved